Industry News
Pharmaceutical Industry News
FDA approves intravenous version of J&J’s Uptravi to prevent treatment interruptions
FDA approves intravenous version of J&J's Uptravi to prevent treatment interruptions ntaylor Tue, 08/03/2021 - 09:32
Eli Lilly’s COVID-19 antibody sales crater as variants, vaccines take a toll
Eli Lilly's COVID-19 antibody sales crater as variants, vaccines take a toll nhigginsdunn Tue, 08/03/2021 - 09:25
BeiGene lays plans for ‘flagship’ biologics plant and R&D center in New Jersey
BeiGene lays plans for 'flagship' biologics plant and R&D center in New Jersey fkansteiner Tue, 08/03/2021 - 08:36
Bristol Myers pulls an Istodax lymphoma use 10 years after FDA accelerated approval
Bristol Myers pulls an Istodax lymphoma use 10 years after FDA accelerated approval aliu Tue, 08/03/2021 - 06:15
AstraZeneca’s launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program
AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program bbulik Mon, 08/02/2021 - 20:29
Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee
Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee fkansteiner Mon, 08/02/2021 - 11:20
FTC drops antitrust case against AbbVie, but still decries the company’s ‘ill-gotten gains’
FTC drops antitrust case against AbbVie, but still decries the company's 'ill-gotten gains' kdunleavy Mon, 08/02/2021 - 11:14
J&J notches a win in $50M talc lawsuit, but tens of thousands still pending
J&J notches a win in $50M talc lawsuit, but tens of thousands still pending bbulik Mon, 08/02/2021 - 10:46
Servier scores a win in bid to expand Tibsovo in acute myeloid leukemia—and reach Europe where Agios failed
Servier scores a win in bid to expand Tibsovo in acute myeloid leukemia—and reach Europe where Agios failed aliu Mon, 08/02/2021 - 10:00
Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report
Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report fkansteiner Mon, 08/02/2021 - 09:34
Aptar inks deal to target Chinese injectable drug delivery field
Aptar inks deal to target Chinese injectable drug delivery field ntaylor Mon, 08/02/2021 - 08:38
Fresh from $225M IPO, atai founds nose-to-brain delivery startup
Fresh from $225M IPO, atai founds nose-to-brain delivery startup ntaylor Mon, 08/02/2021 - 08:35
AstraZeneca nabs FDA nod to challenge GSK’s Benlysta with first-in-class lupus drug Saphnelo
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo aliu Mon, 08/02/2021 - 08:00
U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturer
Emergent BioSolutions, which ruined 75 million vaccine doses at its Baltimore plant, disclosed records requests from Congress and federal and state law enforcement agencies.
With expanded FDA nod, Regeneron’s COVID-19 antibody drug can help the immunocompromised
With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised kdunleavy Fri, 07/30/2021 - 14:05
AbbVie’s post-Humira stalwarts Skyrizi, Rinvoq performing exactly as hoped, CEO says
AbbVie's post-Humira stalwarts Skyrizi, Rinvoq performing exactly as hoped, CEO says nhigginsdunn Fri, 07/30/2021 - 11:38
BeiGene tees up 3-way leukemia competition against J&J-AbbVie, AstraZeneca with Brukinsa win
BeiGene tees up 3-way leukemia competition against J&J-AbbVie, AstraZeneca with Brukinsa win aliu Fri, 07/30/2021 - 11:32
U.K. slaps Advanz Pharma with $140M fine after 1,110% price hike on ‘crucial’ thyroid drug
U.K. slaps Advanz Pharma with $140M fine after 1,110% price hike on 'crucial' thyroid drug fkansteiner Fri, 07/30/2021 - 11:27
From accelerated approval to the TV airwaves: GBT debuts first DTC campaign for sickle cell med Oxbryta
From accelerated approval to the TV airwaves: GBT debuts first DTC campaign for sickle cell med Oxbryta bbulik Fri, 07/30/2021 - 11:07
Senate takes aim at pharma’s patent schemes, pay-for-delay deals in renewed drug pricing crackdown
Senate takes aim at pharma's patent schemes, pay-for-delay deals in renewed drug pricing crackdown kdunleavy Fri, 07/30/2021 - 10:47